{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:36:31Z","timestamp":1774028191380,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jbspin.2007.06.011","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T15:15:23Z","timestamp":1202915723000},"page":"315-318","source":"Crossref","is-referenced-by-count":49,"title":["Onset or exacerbation of cutaneous psoriasis during TNF\u03b1 antagonist therapy"],"prefix":"10.1016","volume":"75","author":[{"given":"Daniel","family":"Wendling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Balblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Brian\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2007.06.011_bib1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1365-4632.2006.03041.x","article-title":"Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event","volume":"45","author":"Aslanidis","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib2","first-page":"316","article-title":"Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy","volume":"16","author":"Cassano","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib3","first-page":"380","article-title":"Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series","volume":"34","author":"Cohen","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","article-title":"Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers","volume":"32","author":"Goiriz","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/ard.2005.037424","article-title":"New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists","volume":"65","author":"Kary","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.06.011_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000095033","article-title":"Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview","volume":"213","author":"Pirard","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jbspin.2007.06.011_bib7","first-page":"438","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?","volume":"34","author":"Richette","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib8","first-page":"434","article-title":"New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?","volume":"34","author":"Roux","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib9","first-page":"1411","article-title":"Anti-tumor necrosis factor-alpha-induced psoriasis","volume":"33","author":"Sari","year":"2006","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jbspin.2007.06.011_bib10","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2007.06.011_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2006.059261","article-title":"A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents","volume":"65","author":"Ritchlin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2007.06.011_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/rheumatology\/kei221","article-title":"In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations","volume":"45","author":"Massara","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2007.06.011_bib13","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2007.06.011_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2005.04.004","article-title":"Cutaneous lymphocytic vasculitis during TNFalpha antagonist therapy for polyarthritis","volume":"73","author":"Wendling","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2007.06.011_bib15","first-page":"247","article-title":"Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy?","volume":"34","author":"Dutz","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2007.06.011_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","article-title":"Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France","volume":"73","author":"Saint Marcoux","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2007.06.011_bib17","first-page":"752","article-title":"Development of Crohn's disease in a patient taking etanercept","volume":"32","author":"Oh","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X08000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T19:51:10Z","timestamp":1546285870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X08000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1297319X08000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2007.06.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}